New ultrasound test may predict chemo success early in breast cancer

NCT ID NCT04715958

Recruiting now Diagnosis Sponsor: Kibo Nam Source: ClinicalTrials.gov ↗

First seen Feb 26, 2026 · Last updated Apr 30, 2026 · Updated 6 times

Summary

This study tests a new ultrasound technique that uses a contrast dye to measure pressure inside breast tumors. The goal is to see if it can predict how well chemotherapy is working early in treatment. 200 women with locally advanced breast cancer will be scanned before and during chemotherapy. If successful, this could help doctors adjust treatment sooner.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Mayo Clinic
RECRUITING

Rochester, Minnesota, 55905, United States

Contact Email: •••••@•••••
Thomas Jefferson University Hospital
RECRUITING

Philadelphia, Pennsylvania, 19107, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
UT Southwestern/Simmons Cancer Center-Dallas
RECRUITING

Dallas, Texas, 75390, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ANATOMIC STAGE III BREAST CANCER AJCC V8 ANATOMIC STAGE III BREAST CANCER AJCC V8 LOCALLY ADVANCED BREAST CARCINOMA